Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Mixanpril
Cat. No.:
OB0425LY-073
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
Mixanpril is a compound that has the ability to modulate insulin sensitivity and femoral artery blood flow.
Synonyms:
156039-69-9; (2S)-2-[[(2S,3R)-2-(Benzoylsulfanylmethyl)-3-phenylbutanoyl]amino]propanoic acid; L-Alanine, N-(2-((benzoylthio)methyl)-1-oxo-3-phenylbutyl)-, (S-(R,S))-
CAS No.:
156039-69-9
Compound CID:
5492682
Formula:
C21H23NO4S
Formula Weight:
385.48
Specification
Target:
Neprilysin
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
Mixanpril can be used as a selective ACE inhibitor.
